Nephron. 2018;140(2):144-147. doi: 10.1159/000490807. Epub 2018 Jun 29.
Renal tubules represent an intercellular unit and function as a syncytium. When acute tubular necrosis was first visualized to occur through a process of synchronized regulated necrosis (SRN) in handpicked primary renal tubules, it became obvious that SRN actually promotes nephron loss. This realization adds to our current understanding of acute kidney injury (AKI)-chronic kidney disease (CKD) transition and argues for the prevention of AKI episodes to prevent CKD progression. Because SRN is triggered by necroptosis and executed by ferroptosis, 2 recently identified signaling pathways of regulated necrosis, a combination therapy employing necrostatins and ferrostatins may be beneficial for protection against nephron loss. Clinical trials in AKI and during the process of kidney transplantation are now required to prevent SRN. Additionally, necrotic cell death drives autoimmunity and necroinflammation and therefore represents a therapeutic target even for the prevention of antibody-mediated rejection of allografts years after the transplantation process.
肾小管代表细胞间的单位,并作为合胞体发挥功能。当急性肾小管坏死首次通过精心挑选的原发性肾小管中的同步调控坏死(SRN)过程被可视化时,很明显 SRN 实际上会促进肾单位丢失。这一认识增加了我们对急性肾损伤(AKI)-慢性肾脏病(CKD)转化的现有理解,并主张预防 AKI 发作以防止 CKD 进展。由于 SRN 是由坏死性凋亡触发的,并由铁死亡执行,作为最近确定的 2 种调控性坏死信号通路,联合使用坏死抑制剂和铁死亡抑制剂的治疗可能有助于防止肾单位丢失。现在需要在 AKI 中进行临床试验,并在肾移植过程中进行临床试验,以防止 SRN。此外,坏死细胞死亡会引发自身免疫和坏死性炎症,因此即使在移植过程多年后预防同种异体移植物的抗体介导排斥反应,也代表着一个治疗靶点。